Meropenem – therapeutic recommendation after twenty years of presence on pharmaceutical market

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue

Abstract

Meropenem is the first representative of carbapenem analogues with methyl group, which has been applied in medicine. This drug has been approved by FDA (Food and Drug Administration) in 1996. Available results of clinical trials and scientific reports point surprising synergism of combination of meropenem with other chemotherapeutics, in the treatment of bacterial diseases. Present study based on available information presents indications for use the mentioned antibiotic in pharmacotherapy of infectious diseases. Meropenem is the first representative of carbapenem analogues, which contains methyl group. Introduction of a methyl group at the system of coupled rings: β-lactam and pyrrolidine, solved the problem of degradation by the dehydropeptidase-I (DHP-I). In the consequence it is not necessary to use meropenem in the connection with specific DHP-I inhibitors. Meropenem, similarly to other carbapanem analogues, is intended for the treatment of severe inpatient and outpatient infections. Bacterial resistance to meropenem may be the result of: carbapenemases activity, decreased affinity to Penicillin Binding Proteins - PBP (mainly PBP 2 and PBP 3) and activation of efflux pump (antibiotic ejection outside the cell). Twenty-year period of application of meropenem in pharmacotherapy may cause the spread of methyl-β-lactamases.

Authors and Affiliations

Magdalena Paczkowska, Piotr Garbacki, Przemysław Zalewski, Alicja Talaczyńska, Judyta Cielecka-Piontek

Keywords

Related Articles

Rho-kinase inhibitor reduces hypersensitivity to ANG II in human mesenteric arteries retrieved and conserved under the same conditions as transplanted organs

Rho-kinase and GTP-ase Rho are important regulators of vascular tone and blood pressure. The aim of this study was to investigate the role of Rho-kinase in artery reactions induced by angiotensin II (ANG II) and the effe...

Białka transportu wewnątrzkomórkowego: klasyfikacja, budowa i funkcje kinezyn

Prawidłowe funkcjonowanie komórki, jej podziały oraz morfogeneza są uzależnione od sprawnego transportu wewnątrzkomórkowego. Obok dynein i miozyn, kinezyny są jednymi z najważniejszych białek odpowiedzialnych za mechaniz...

Selected genetic determinants of head and neck squamous cell carcinoma including of some genes for cell cycle control and DNA repair

The head and neck squamous cell carcinoma, which are located in different anatomical structures like: oral cavity, throat and larynx, are becoming a major clinical problem due to the ever increasing number of cases and a...

[u][/u] Oksydacyjnie modyfikowane i deaminowane zasady DNA jako czynnik epigenetyczny

Omawiane w pracy wyniki badań wskazują, że 5-metylocytozyna (5mC) może ulegać hydroksylacji do 5-hydroksymetylocytozyny (5hmC), a jej zawartość w genomie ssaków ocenia się na około 0,02–0,7% całkowitej zawartości cytozy...

Znaczenie podwyższenia i obniżenia aktywności proteasomów w patomechanizmie wybranych schorzeń

Aktywność proteasomów (P), wewnątrzkomórkowych struktur odpowiedzialnych za rozkład białek, wpływa znacząco na przebieg głównych procesów biologicznych. Obniżenie aktywności proteasomów upośledza rozpad patologicznych bi...

Download PDF file
  • EP ID EP67350
  • DOI -
  • Views 124
  • Downloads 0

How To Cite

Magdalena Paczkowska, Piotr Garbacki, Przemysław Zalewski, Alicja Talaczyńska, Judyta Cielecka-Piontek (2014). Meropenem – therapeutic recommendation after twenty years of presence on pharmaceutical market. Advances in Hygiene and Experimental Medicine, 68(), 441-445. https://europub.co.uk/articles/-A-67350